![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Clears Dual-Lead Nerve Stimulator for Pain Relief
FDA Clears Dual-Lead Nerve Stimulator for Pain Relief
August 21, 2018
SPR Therapeutics’ received FDA clearance for its single and dual lead peripheral nerve stimulator.
The devices are minimally invasive alternatives to opioids that are implanted for up to 60 days to relieve acute and chronic pain, including post-traumatic and post-operative pain. The components are removed after treatment.
The nerve stimulator comes with a wearable electronic pulse generator that has rechargeable batteries and a Bluetooth compatible remote.
Upcoming Events
-
21Oct